Metraipolis › archive › dc_61310e3fd5d2

Dapagliflozin attenuates diabetic renal fibrosis by inhibiting macrophage-myofibroblast transition via the TGF-β1-Smad3/7 pathway — Europe PMC PMID:42254676

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42254676
DOI
10.7717/peerj.21321
License (as archived)
solo-consultazione
Archived
2026-10-31T21:42:12.551Z
SHA-256 of the archived text
3a8dff259231be41dec2a08e0448f98a962273f06c9b6715a39c8d4cd71ae35b
Stable URL of this page
https://metraipolis.com/documento/dc_61310e3fd5d2

How to cite

Dapagliflozin attenuates diabetic renal fibrosis by inhibiting macrophage-myofibroblast transition via the TGF-β1-Smad3/7 pathway — Europe PMC PMID:42254676 — Europe PMC (en), https://europepmc.org/article/MED/42254676 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61310e3fd5d2 (Metraipolis archive dc_61310e3fd5d2, sha256 3a8dff259231be41dec2a08e0448f98a962273f06c9b6715a39c8d4cd71ae35b)
BibTeX
@misc{dc61310e3fd5d2,
  title = {Dapagliflozin attenuates diabetic renal fibrosis by inhibiting macrophage-myofibroblast transition via the TGF-β1-Smad3/7 pathway — Europe PMC PMID:42254676},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42254676},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61310e3fd5d2; sha256 3a8dff259231be41dec2a08e0448f98a962273f06c9b6715a39c8d4cd71ae35b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42254676. Agents can read the archived copy with the MCP tool read_document.